Yubo International Biotech Ltd
YBGJ· OTC
Filed Jul 12, 2012 · 10-Q · 42 days after period end · 0001193805-12-001167
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$23.00K | -$23.00K |
| EPS Diluted | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
ended May 31, 2012 · filed Jul 12, 2012 · 42 d after period end